Jointly research and develop conventional defense technology with allies and friendly partners
Enter cooperative R&D agreements, share cash and noncash project costs, and acquire domestic or foreign equipment for side-by-side testing.
Enter Five Eyes agreements covering medical R&D/trials, education, credentialing, biodefense, logistics and patient movement.
Authority holder: Secretary of Defense.
Mechanism tags describe the source text; they do not expand the authority.
Existing statutory pathway; conditional on the listed findings, approvals, eligible purpose and actual available funds. Not an obligation-ready certification.
Office links are editorial matches to the original role text, not verified delegations. Composite labels and unmatched actors are preserved.
Medical capability need → DHA/Service research or operational sponsor → agreement/legal/fiscal review → Five Eyes arrangement → accountable execution.
Confidence: High on express statutory capability; execution/delegation and currently available resources require program-specific confirmation.
Currentness: New §2350t enacted in Pub. L. 119-60 §715 on 2025-12-18; enacted text read. First annual report due one year after enactment. Later amendment delta not certified.
Research target: October 2, 2026. A record-specific last-review date is not supplied. Publication date is not legal-currentness certification.